Evasion of host immunity directed by papillomavirus-encoded proteins.
about
The Canine Papillomavirus E5 Protein Signals from the Endoplasmic ReticulumHighly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy-assisted gene expression profiling.Interferons and their stimulated genes in the tumor microenvironmentAssociation of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in BrazilA conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells.Persistence of human papillomavirus infection: keys to malignant progressionPapillomavirus E5: the smallest oncoprotein with many functions.HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.Immunology and Immunotherapy of Head and Neck CancerHypoxia-specific stabilization of HIF-1alpha by human papillomavirusesSafety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses.Immunologic treatments for precancerous lesions and uterine cervical cancer.Urban legends series: oral manifestations of HIV infection.Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?Immunotherapy and targeted therapy for cervical cancer: an update.Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies.The human papillomavirus E7 oncoprotein as a regulator of transcription.Novel Approaches for Vaccination Against HPV-Induced Cancers.The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells.HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells.Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis.HLA-G 3' untranslated region polymorphisms influence the susceptibility for human papillomavirus infection.The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface.HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus.The effect of paralogous lineages on the application of reconciliation analysis by cophylogeny mapping.S100, CD68, and MHC class II molecule expression in cervical high- and low-grade HPV-induced lesions.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
P2860
Q27490470-D2ECBA02-479A-4E2A-AD2C-35C138BD95B1Q30835820-0B16F407-3508-46CC-8BA5-A6C1B901196FQ33988567-994ABB61-4D54-4B07-997C-F78EAAB4A53EQ34041963-8A8CEB02-F68C-497C-B7BA-C9AC07601113Q34121681-D6B53D3A-3036-4189-B45C-27A0A7B698FAQ34296041-27B6413E-E2A7-4B6B-BB3B-C59F1EDC7BA6Q34395881-7B0847A0-EE80-443A-8F90-06D2A9C25893Q34690139-A09DC92A-29B2-4451-BAFB-CC6D951A426CQ35642759-99D55C09-B3C8-4F66-998D-B2FAEB6880A0Q35762184-D7A78136-D31B-4563-83D3-86D45D43EACBQ36100837-D7429D70-A0A7-493C-A671-5BE6DCDD2E48Q37171664-F6498D9E-98B8-413B-A8C1-A2BCA06E40FDQ37612161-D78AEE64-84FE-4BCE-B6DC-75D78D84FE2CQ37703113-857935EC-2DC0-40A6-A465-310313D90480Q38091715-D530272E-0709-4123-A086-A81B8537164AQ38542639-9B970219-C6A3-4651-8F3F-2042D986D0CCQ38633525-F33202A9-9C53-408F-9E9C-FA27E6082FF9Q38851114-85C79196-8093-4202-B6CB-1818B6293E2AQ39000409-8D20E24C-2919-4C8D-8604-C4B58221D872Q39033362-9A8CD9AE-D9D1-4555-B5A8-A2F109FD938EQ40059928-79CD1C75-728C-4787-B3C1-8BF46782F3DCQ40092543-8F5B6EC4-EA77-4522-BA69-940E1871EAEAQ40304304-764D1F85-098E-4526-B935-5303DEACAF13Q42222795-2B16D1E3-6370-4CB8-8853-87443FCDF7BFQ44208144-A9F82B6D-B117-4EB5-A5F7-55B32B945934Q45200038-14BE2116-9EEB-4212-A303-6ACA303022A4Q48144454-E1FE9A8E-5DA0-4C7C-9330-410FD8EB6D57Q53654998-8DFAAFC9-011C-48E1-A799-C15B00AAC0C6Q55003290-6092153A-E0A3-4724-9E6D-58F16080CAE3
P2860
Evasion of host immunity directed by papillomavirus-encoded proteins.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evasion of host immunity directed by papillomavirus-encoded proteins.
@ast
Evasion of host immunity directed by papillomavirus-encoded proteins.
@en
Evasion of host immunity directed by papillomavirus-encoded proteins.
@nl
type
label
Evasion of host immunity directed by papillomavirus-encoded proteins.
@ast
Evasion of host immunity directed by papillomavirus-encoded proteins.
@en
Evasion of host immunity directed by papillomavirus-encoded proteins.
@nl
prefLabel
Evasion of host immunity directed by papillomavirus-encoded proteins.
@ast
Evasion of host immunity directed by papillomavirus-encoded proteins.
@en
Evasion of host immunity directed by papillomavirus-encoded proteins.
@nl
P1433
P1476
Evasion of host immunity directed by papillomavirus-encoded proteins.
@en
P2093
M Saveria Campo
Philippa M O'Brien
P304
P356
10.1016/S0168-1702(02)00123-5
P577
2002-09-01T00:00:00Z